<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02882568</url>
  </required_header>
  <id_info>
    <org_study_id>P15/19_ARIIBO</org_study_id>
    <nct_id>NCT02882568</nct_id>
  </id_info>
  <brief_title>Analysis of Immune Response In Bacterial Infection of Obese Subject</brief_title>
  <acronym>ARIIBO</acronym>
  <official_title>Analysis of Immune Response In Bacterial Infection of Obese Subject</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Improve knowledge of the immune response to sepsis in obese patients. Define immunological
      and genetic prognostic factors of severe infections which can motivate a change in the
      therapeutic attitude
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patterns of inflammatory and immunological markers in obese patients in sepsis and post- sepsis (&quot;normal&quot;) situation</measure>
    <time_frame>T 0 and at 1 month</time_frame>
    <description>Standard inflammatory markers; immunological markers (cytokines, leptine, lymphocyte phenotype)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of sepsis; correlation with inflammatory and immunological parameters</measure>
    <time_frame>T 0 and at 1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of leptine polymorphism</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>investigational</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood test for Inflammatory and immunological analysis during acute sepsis phase and one month later</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood analysis</intervention_name>
    <description>Pilot study, single center, interventional including 15 obese subjects with acute sepsis. Inflammatory and immunological tests during acute phase and one month later after a presumed return parameters at baseline</description>
    <arm_group_label>investigational</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  between18 and 80 years

          -  obesity: BMI &gt; 30

          -  presumed bacterial infection:

               -  pneumonitis (documented or probably)

               -  pyelonephritis / acute prostatitis

               -  soft tissue / skin infection (except for bedsore)

               -  cholecystitis / angiocholitis

               -  meningitis

               -  clostridium colitis

               -  surgical site infection

          -  signed consent

        Exclusion Criteria:

          -  patients with viral, parasitic or mycotic documented infection

          -  patients with bacterial infection with treatment&gt; 4 weeks (ex. endocarditis; osteo-
             articular infections)

          -  patients with prior antibiotic treatment (&lt; 14 days)

          -  intensive care unit patients

          -  patients with a history of cancer or malignant hematological disease within the 5
             previous years that is currently clinically significant (non metastatic prostatic and
             basocellular malignancy are excluded)

          -  patients with systemic disease

          -  Known diagnosis of human immunodeficiency infection (DICV, HIVâ€¦)

          -  immunosuppression treatment during last month including corticotherapy

          -  pregnancy

          -  3 months follow up not possible

          -  non signed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ch de Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <last_update_submitted>December 19, 2017</last_update_submitted>
  <last_update_submitted_qc>December 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Roderick Meckenstock</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

